We'll reply to your email within 24 hours

Classic BPC-157 and TB-500 combination for recovery research.
SKU: BPCTB-STD
BPC-157 + TB-500 combines two of the most extensively researched regenerative peptides: the gastric pentadecapeptide BPC-157 and the actin-sequestering peptide Thymosin Beta-4 (TB-500). This combination targets complementary pathways in tissue repair, offering researchers a comprehensive approach to studying regenerative mechanisms.
The theoretical synergy between these peptides arises from their distinct but overlapping mechanisms—BPC-157's cytoprotective and angiogenic effects complementing TB-500's cell migration and anti-inflammatory properties.
Each peptide contributes unique mechanisms to tissue repair:
| Mechanism | BPC-157 | TB-500 |
|---|---|---|
| Angiogenesis | VEGFR2 pathway activation | VEGF upregulation |
| Cell Migration | FAK-paxillin activation | G-actin sequestration |
| Anti-inflammatory | Cytokine modulation | miR-146a upregulation |
| Tissue Repair | Growth hormone receptor upregulation | Collagen deposition |
| Primary Target | Gastrointestinal & musculoskeletal | Connective tissue & cardiovascular |
The combination addresses multiple phases of the wound healing cascade simultaneously.
The BPC-157 + TB-500 combination is being studied for potential effects on:
Preclinical research suggests potential synergistic effects, though combination studies remain limited.
BPC-157:
TB-500 (Thymosin Beta-4):
FOR RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION. This product is intended for laboratory and research purposes only. Not for human or animal consumption.
Based on 1 review
4 February 2026
Very happy with purchase, please get tb as a single vial also.